5-alpha-dihydrotestosterone elevations associated with phentermine use.
Scott M PearsonJennifer M TrujilloMichael T McDermottPublished in: Therapeutic advances in endocrinology and metabolism (2018)
A 72-year-old male with metastatic prostate cancer experienced profound increases in DHT upon initiation of phentermine despite continuation of his baseline dutasteride therapy. The etiology of these increases is still unclear.